ArticleFrontiers in immunology2025

HER2-positive breast cancer with invasive micropapillary carcinoma component shows immunosuppressive microenvironment and resistance to neoadjuvant therapy.

Lulu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.